OBRI-IBD Inflammatory Bowel Disease Biobank, Canada

Mono: A biobank that supports a specific research project, may have few staff members, a small-scale accrual scope with little to no initial intention of releasing or distributing biospecimens to secondary parties
Oligo: A biobank that supports several research groups or clinical trials, may or may not be designed to release biospecimens outside their collaborative group
Poly: A biobank that has generally a larger accrual scope, resources, and multiple users outside the biobank proper

Registration Status: Pending

Objective: We are seeking to collect biospecimen linked to clinical data and patient reported outcomes for Canadians with IBD who are using or are highly likely to use biologic and other highly active therapies

Registered Biobank Name	OBRI-IBD Inflammatory Bowel Disease Biobank
Biobank Leader	Laura.Targownik@sinaihealth.ca
Country	Canada
Email for biobank inquiries	Laura.Targownik@sinaihealth.ca
Principal Investigator	Laura Targownik
User Type Mono: A biobank that supports a specific research project, may have few staff members, a small-scale accrual scope with little to no initial intention of releasing or distributing biospecimens to secondary parties Oligo: A biobank that supports several research groups or clinical trials, may or may not be designed to release biospecimens outside their collaborative group Poly: A biobank that has generally a larger accrual scope, resources, and multiple users outside the biobank proper

Biospecimen Collected: